Discover
SION
Sionna Therapeutics, Inc.
5.10
1 x 4.92
1 x 5.05
bid
ask
+
0.60
13.33%
8 @ 04:00 PM
5.00 -0.10 (1.94%)
| Ytd | -87.60% | |
| 1y | -74.54% |
4.49
day range
5.48
4.01
52 week range
54.97
| Open | 4.50 | Prev Close | 4.50 | Low | 4.49 | High | 5.48 | Mkt Cap | 230.27M |
| Vol | 0.00 | Avg Vol | 1.10M | EPS | -2.18 | P/E | -2.34 | Forward P/E | -18.18 |
| Beta | 1.33 | Short Ratio | 10.62 | Inst. Own | 100.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 41.67 | 200-d Avg | 40.08 | 1yr Est | 53.20 |
| Income Statement | |||
| Operating Expenses | 32.47M | ||
| Research and Development Expense | 21.86M | ||
| Selling, General and Administrative Expense | 10.61M | ||
| Operating Income | -32.47M | ||
| Net Income | -29.89M | ||
| Net Income Common Stock | -29.89M | ||
| Net Income Common Stock (USD) | -29.89M | ||
| Consolidated Income | -29.89M | ||
| Earnings per Basic Share | -0.66 | ||
| Earnings per Basic Share (USD) | -0.66 | ||
| Earnings per Diluted Share | -0.66 | ||
| Earning Before Interest & Taxes (EBIT) | -29.89M | ||
| Earning Before Interest & Taxes (USD) | -29.89M | ||
| Weighted Average Shares | 45.15M | ||
| Weighted Average Shares Diluted | 45.15M | ||
| Balance Sheet | |||
| Cash and Equivalents | 64.29M | ||
| Cash and Equivalents (USD) | 64.29M | ||
| Investments | 204.93M | ||
| Investments Current | 147.71M | ||
| Investments Non-Current | 57.22M | ||
| Current Assets | 216.13M | ||
| Property, Plant & Equipment Net | 8.34M | ||
| Total Assets | 283.25M | ||
| Debt Current | 1.38M | ||
| Total Debt | 8.07M | ||
| Current Liabilities | 10.78M | ||
| Debt Non-Current | 6.69M | ||
| Total Liabilities | 17.47M | ||
| Accumulated Retained Earnings (Deficit) | -313.02M | ||
| Accumulated Other Comprehensive Income | -448.00K | ||
| Shareholders Equity | 265.77M | ||
| Shareholders Equity (USD) | 265.77M | ||
| Assets Non-Current | 67.12M | ||
| Total Debt (USD) | 8.07M | ||
| Liabilities Non-Current | 6.69M | ||
| Trade and Non-Trade Payables | 523.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 647.00K | ||
| Net Cash Flow from Financing | 749.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.00K | ||
| Issuance (Purchase) of Equity Shares | 979.00K | ||
| Net Cash Flow from Investing | 21.47M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 21.47M | ||
| Net Cash Flow from Operations | -22.22M | ||
| Share Based Compensation | 6.84M | ||